<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en-US" data-colors-preset="contrast" data-primary-color="#307FFF"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="UTF-8"><meta name="robots" content="noindex">  <meta name="built-on" content="2024-01-01T13:15:31.960335"><meta name="build-number" content="${buildNumber}">       <title>监管重拳出击，两天三家药企因蹭热点收警示函 | 2023-10-18</title><script id="virtual-toc-data" type="application/json">[]</script><script id="topic-shortcuts" type="application/json"></script><link href="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.css" rel="stylesheet">   <link rel="apple-touch-icon" sizes="180x180" href="https://jetbrains.com/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="https://jetbrains.com/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="https://jetbrains.com/favicon-16x16.png"><link rel="manifest" href="https://jetbrains.com/site.webmanifest"><link rel="mask-icon" href="https://jetbrains.com/safari-pinned-tab.svg" color="#000000"><meta name="msapplication-TileColor" content="#000000"/><meta name="msapplication-TileImage" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-144x144.png"/><meta name="msapplication-square70x70logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-70x70.png"/><meta name="msapplication-square150x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-150x150.png"/><meta name="msapplication-wide310x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x150.png"/><meta name="msapplication-square310x310logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x310.png"/>  <meta name="image" content=""><!-- Open Graph --><meta property="og:title" content="监管重拳出击，两天三家药企因蹭热点收警示函 | 2023-10-18"/><meta property="og:description" content=""/><meta property="og:image" content=""/><meta property="og:site_name" content="2023-10-18 Help"/><meta property="og:type" content="website"/><meta property="og:locale" content="en_US"/><meta property="og:url" content="8848.html"/><!-- End Open Graph --><!-- Twitter Card --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content=""><meta name="twitter:title" content="监管重拳出击，两天三家药企因蹭热点收警示函 | 2023-10-18"><meta name="twitter:description" content=""><meta name="twitter:creator" content=""><meta name="twitter:image:src" content=""><!-- End Twitter Card --><!-- Schema.org WebPage --><script type="application/ld+json"> { "@context": "http://schema.org", "@type": "WebPage", "@id": "8848.html#webpage", "url": "8848.html", "name": "监管重拳出击，两天三家药企因蹭热点收警示函 | 2023-10-18", "description": "", "image": "", "inLanguage":"en-US" }</script><!-- End Schema.org --><!-- Schema.org WebSite --><script type="application/ld+json"> { "@type": "WebSite", "@id": "/#website", "url": "/", "name": "2023-10-18 Help" }</script><!-- End Schema.org --></head>      <body data-id="8848" data-main-title="监管重拳出击，两天三家药企因蹭热点收警示函" data-article-props="{&quot;seeAlsoStyle&quot;:&quot;links&quot;}"  data-template="article"  data-breadcrumbs=""  >   <div class="wrapper"><main class="panel _main"><header class="panel__header"><div class="container"><h3>2023-10-18  Help</h3><div class="panel-trigger"></div></div></header><section class="panel__content"><div class="container"><article class="article" data-shortcut-switcher="inactive"><h1 data-toc="8848"   id="8848.md">监管重拳出击，两天三家药企因蹭热点收警示函</h1>  <p id="95bed727_7"><span class="control" id="95bed727_8">一财资讯</span></p><p id="95bed727_9"><span class="control" id="95bed727_10">2023-10-18 13:42</span></p><p id="95bed727_11"><span class="control" id="95bed727_12">https://www.yicai.com/news/101878842.html</span></p><figure  id="95bed727_13"><img alt="C2d42922f444f54696e4a34c0b61fbbf" src="https://imgcdn.yicai.com/uppics/slides/2023/10/c2d42922f444f54696e4a34c0b61fbbf.jpg" title="C2d42922f444f54696e4a34c0b61fbbf"   ></figure><p id="95bed727_14">近两天，三家上市药企收警示函。收到警示函的原因均涉及&ldquo;蹭&rdquo;GLP-1类减肥药热点。</p><p id="95bed727_15">10月18日，百花医药公告，公司在&ldquo;e互动&rdquo;、2023年半年度业绩说明会及相应公告中多次披露减肥类产品相关信息，但未明确、充分说明利拉鲁肽、司美格鲁肽相关项目暂无任何客户委托公司研发等情况，信息披露不准确、不完整，新疆证监局对公司及董事会秘书蔡子云采取出具警示函的监督管理措施。</p><p id="95bed727_16">同一日，康惠制药公告，因公司于10月13日、10月16日针对孙公司陕西友帮是否可生产降糖/减肥药物司美格鲁肽、替泊尔肽中间体的问题前后回复不一致，信息披露不准确、不完整，不符合《上市公司信息披露管理办法》第三条规定。证监会决定对公司及王延岭、董娟采取出具警示函的行政监管措施。</p><p id="95bed727_17">就在昨日，博瑞医药公告，董事长在电话会议上关于公司在研产品BGM0504注射液药效的相关言论具有误导性，江苏证监局决定对其采取出具警示函的行政监管措施。从警示函内容可以看出，上述三家药企收到警示函的原因均涉及&ldquo;蹭&rdquo;GLP-1类减肥药热点。</p><p id="95bed727_18">除了上述三家公司外，近期还有苏大维格因在投资者互动平台上&ldquo;蹭热点&rdquo;而受到监管处罚。10月13日，因在互动易平台上的&ldquo;光刻机&rdquo;误导性陈述，苏大维格收到江苏证监局下发的《行政处罚事先告知书》，江苏证监局拟决定对苏大维格给予警告，并处150万元罚款；对苏大维格董事会秘书蒋林给予警告，并处以一百万元罚款。</p><p id="95bed727_19">梳理发现，今年以来，还有南方精工、罗曼股份、传艺科技等多家上市公司因互动易信息披露问题收到监管层处罚，原因涉及在投资者互动平台&ldquo;风险提示不充分&rdquo;、&ldquo;误导性陈述&rdquo;、&ldquo;信息抢跑&rdquo;和&ldquo;回应内容不准确&rdquo;等。</p><div class="last-modified"> Last modified: 01 一月 2024</div><div data-feedback-placeholder="true"></div><div class="navigation-links _bottom">  <a class="navigation-links__prev" href="8850.html">平安健康换帅：方蔚豪辞任，李斗接棒董事会主席兼CEO</a>   <a class="navigation-links__next" href="8847.html">财联社10月18日电，土耳其基准股指跌幅扩大至3%。</a>  </div></article><div id="disqus_thread"></div></div></section></main></div>  <script src="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.js"></script></body></html>